Why do some β adrenergic agonists inhibit generation of thromboxane A2 in incubates of platelets with arachidonic acid?
- 1 January 1978
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 27 (11), 1603-1606
- https://doi.org/10.1016/0006-2952(78)90492-6
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Role of prostaglandin endoperoxide PGG2 in inflammatory processesNature, 1977
- On the Formation and Effects of Thromboxane A2 in Human PlateletsActa Physiologica Scandinavica, 1976
- Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acidInflammation Research, 1975
- Cyclic nucleotides and modulation of effector systems of inflammationBiochemical Pharmacology, 1974
- Search for Common Mechanisms Underlying the Various Effects of Putative Inflammatory MediatorsPublished by Springer Nature ,1974
- Isolation and properties of intermediates in prostaglandin biosynthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973
- Aspirin Selectively Inhibits Prostaglandin Production in Human PlateletsNature New Biology, 1971
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971
- EFFECT OF SALICYLATES ON HUMAN PLATELETSThe Lancet, 1968
- EFFECTS OF SALICYLATES ON HUMAN PLATELETSThe Lancet, 1968